Paul J. Hastings - Jul 11, 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jul 11, 2022
Transactions value $
-$30,354
Form type
4
Date filed
7/13/2022, 04:03 PM
Previous filing
Jun 21, 2022
Next filing
Sep 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$30.4K -533 -6.91% $56.95 7.18K Jul 11, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.